advertisement

Saturday, July 5, 2008
Cancer Center
Acute Lymphocytic Leukemia
AboutPreventionSymptomsTestsTreatmentManaging

Biological Therapy: Monoclonal Antibodies

Biological therapy, also know as immunotherapy, bolsters your immune system to help your body kill leukemia cells or slow their growth. Biological therapy can be used to treat patients with acute lymphocytic leukemia (ALL). Patients with leukemia are treated with monoclonal antibodies, special proteins that are developed in a laboratory. They are similar to the antibodies that are produced by the immune system but are created to specifically react with certain types of cancer cells.

Multimedia

Video: Health Features

Related Links
Bullet National Library of Medicine
Bullet American Cancer Society
Bullet The Leukemia and Lymphoma Society
0
Email this sectionEmail this pagePrint this sectionPrint this section
0
0
0

Rituximab (Rituxan) is the monoclonal antibody used in treating patients with ALL. Other than the chance of developing fever, this drug has few side effects. Occasionally, patients with very high white blood cell counts can develop kidney problems because rituximab kills the cells so quickly that the body sometimes has trouble metabolizing all the breakdown products of the dead cells. This can overtax the kidneys.

Content last updated: //Previous PagePrevious page Next PageNext Page




U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.

advertisement

advertisement

advertisement


Copyright © 2007 U.S.News & World Report, L.P. All rights reserved.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.